MOTS-c — energy, exercise and ageing

What is MOTS-c?

MOTS-c is a peptide made of sixteen amino acids. The information needed to produce it is encoded in mitochondrial DNA, in the parts of the cell involved in energy production. Researchers are examining how this signal relates to muscle function and the body's response to insulin. [35]

Insulin helps regulate blood glucose and nutrient use. When cells respond less well, this is called insulin resistance. MOTS-c's connection with these processes is a reason for research, not proof that it is an available treatment for the problem.

What did the first experiments show?

Cell and mouse studies examined measures including insulin response and the effects of a high-fat diet. Findings justified further research. However, benefits after administration concerned animals, not patients treated for diabetes. [35]

Animal research allows an idea to be tested under controlled conditions. Before it becomes a treatment for people, researchers still need to establish whether the effect is reproducible, whom it benefits and what risks accompany it.

Can MOTS-c replace exercise?

There is no basis for that claim. In a well-known 2021 paper, ten young men exercised on a bicycle. Researchers measured MOTS-c naturally present in their blood and muscles. Participants were not given the peptide. A rise after exercise does not demonstrate exercise in an injection. [36]

Administering the peptide and testing performance in mice formed a different part of the paper. Combining both parts into one claim of improved human endurance would be misleading. [36]

What is currently being tested in humans?

A registry entry called MOTS-MET appeared in 2026. It describes a comparison of MOTS-c with placebo in people with prediabetes and excess body weight. Insulin response and safety are to be assessed. No results had been published in the registry when it was checked. [37]

You may also encounter CB4211. It is an analogue, a modified substance, not another name for identical MOTS-c. Its earlier study should not be presented as evidence for every MOTS-c product. [38] [39]

What do we not know about safety?

In July 2026 materials, the FDA noted a lack of adequate clinical data on the effectiveness of MOTS-c itself and important safety-assessment gaps. It also highlighted product quality and possible immune reactions. How often these problems occur in humans has not been established. [40]

The October HHS draft compounding policy also covers MOTS-c acetate. It is not drug approval or confirmation that administering it to people is safe. [51] [52]

What about sport and longevity?

WADA lists MOTS-c among metabolic modulators in section S4.4.1. In sport governed by its rules, it is prohibited both in and out of competition. [54]

There is no basis for promising a longer human life. Performance in a specific test, a blood test result and lifespan are different outcomes. Each requires separate assessment.

Where can I read more?

MOTS-c: from exercise research to a new human trial and Peptides and longevity: what should you check in a paper?.

Where does this information come from?